Chimeric cytotoxin IL2-PE40 inhibits relapsing experimental allergic encephalomyelitis

This publication has 14 references indexed in Scilit:

• IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells.
  The Journal of Immunology, 1990
• Immunotherapy of experimental autoimmune encephalomyelitis (EAE): Differential effect of anti-IL-2 receptor antibody therapy on actively induced and T-line mediated EAE of the Lewis rat
  Journal of Autoimmunity, 1989
• IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors.
  The Journal of Immunology, 1988
• Exotoxin A of Pseudomonas aeruginosa: substitution of glutamic acid 553 with aspartic acid drastically reduces toxicity and enzymatic activity
  Journal of Bacteriology, 1987
• Receptor-Affinity Chromatography: A One-Step Purification for Recombinant Interleukin-2
  Nature Biotechnology, 1987
• Autoimmune effector cells. IX. Inhibition of adoptive transfer of autoimmune encephalomyelitis with a monoclonal antibody specific for interleukin 2 receptors.
  The Journal of Immunology, 1987
• Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system.
  The Journal of Experimental Medicine, 1987
• Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli
  Cell, 1987
• Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.
  The Journal of Experimental Medicine, 1985
• Large Scale Preparation of Myelin Basic Protein from Central Nervous Tissue of Several Mammalian Species
  Preparative Biochemistry, 1972